Biocon Biologics
Tripti Singh has a wealth of experience in information technology, project management, and compliance. With a background in SAP, Tripti has successfully led various projects and initiatives in different companies. Tripti is currently serving as the Head of Information Technology for Biocon Biologics in North America, while also holding a position as an Adjunct Professor at Rutgers Business School. Tripti 's strategic mindset and strong leadership skills have enabled their to drive digital transformation and ensure IT compliance in their roles. Tripti's educational background includes executive programs from top universities such as Wharton, Harvard, and MIT Sloan, along with master's degrees in Economics from the University of Lucknow.
This person is not in any offices
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics